Resistance to Second-Line Antibiotics in Mycoplasma pneumoniae Isolates From Children in East Asia: A Systematic Review and Meta-analysis

Background: Macrolide-resistant Mycoplasma pneumoniae (MRMP) is a therapeutic challenge in children, especially in East Asia. Tetracyclines and fluoroquinolones are alternatives when macrolides fail, but their in vitro resistance rates have not been synthesized by susceptibility-testing method. Methods: A unified search, with Chinese and English strings as block-for-block mirror images, covered six databases to September 1, 2026. Of 1,136 records, 700 remained after deduplication. Twenty pediatric studies were eligible; eleven tested cultured isolates by standardized dilution and formed the primary analysis of all isolates regardless of macrolide-resistance status, one contributed to sensitivity analysis, and eight were descriptive. Because all primary analyses observed zero events, results are pooled as 0.00% with exact upper 95% bounds. Results: No resistant isolate was observed for any second-line agent by each study's own criteria. Pooled resistance was 0.00% for tetracycline (n=2,353; upper bound 0.16%), levofloxacin (n=2,175; 0.17%), minocycline (n=1,545; 0.24%), moxifloxacin (n=805; 0.46%), and doxycycline (n=608; 0.60%); resistance was zero for both all-isolate and macrolide-resistant denominators. Interpretive criteria differed; a sensitivity analysis limited to CLSI M43-A studies gave the same result. One serology-based study without cultured isolates was not pooled. Conclusions: Across China and Japan (2002-2025), no cultured isolate resistant to tetracyclines or fluoroquinolones was observed. Absence of observed resistance is not evidence of absence: upper bounds (0.16%-0.60%) remain compatible with low-frequency resistance. Macrolides remain first-line; second-line agents retain activity, but standardized surveillance is needed.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11747171/v1
Primary Topic
Microbial infections and disease research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Resistance to Second-Line Antibiotics in Mycoplasma pneumoniae Isolates From Children in East Asia: A Systematic Review and Meta-analysis

Chen Shen, Deze Li², Hao Chen
Research Square
Microbial infections and disease research
preprint

Resistance to Second-Line Antibiotics in Mycoplasma pneumoniae Isolates From Children in East Asia: A Systematic Review and Meta-analysis

Chen Shen, Deze Li², Hao Chen
preprint en

Abstract

Background: Macrolide-resistant Mycoplasma pneumoniae (MRMP) is a therapeutic challenge in children, especially in East Asia. Tetracyclines and fluoroquinolones are alternatives when macrolides fail, but their in vitro resistance rates have not been synthesized by susceptibility-testing method. Methods: A unified search, with Chinese and English strings as block-for-block mirror images, covered six databases to September 1, 2026. Of 1,136 records, 700 remained after deduplication. Twenty pediatric studies were eligible; eleven tested cultured isolates by standardized dilution and formed the primary analysis of all isolates regardless of macrolide-resistance status, one contributed to sensitivity analysis, and eight were descriptive. Because all primary analyses observed zero events, results are pooled as 0.00% with exact upper 95% bounds. Results: No resistant isolate was observed for any second-line agent by each study's own criteria. Pooled resistance was 0.00% for tetracycline (n=2,353; upper bound 0.16%), levofloxacin (n=2,175; 0.17%), minocycline (n=1,545; 0.24%), moxifloxacin (n=805; 0.46%), and doxycycline (n=608; 0.60%); resistance was zero for both all-isolate and macrolide-resistant denominators. Interpretive criteria differed; a sensitivity analysis limited to CLSI M43-A studies gave the same result. One serology-based study without cultured isolates was not pooled. Conclusions: Across China and Japan (2002-2025), no cultured isolate resistant to tetracyclines or fluoroquinolones was observed. Absence of observed resistance is not evidence of absence: upper bounds (0.16%-0.60%) remain compatible with low-frequency resistance. Macrolides remain first-line; second-line agents retain activity, but standardized surveillance is needed.

Research Square
Beijing Children’s Hospital (CN)
Microbial infections and disease research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon